Specific ACKR2 modulators for use in therapy

Bassam Janji (Inventor), Muhammad Zaeem Noman (Inventor), Andy Chevigne (Inventor), Martyna Szpakowska (Inventor), Guy Berchem (Inventor), Markus Ollert (Inventor)

Research output: Patent


The application discloses a specific ACKR2 modulator for use in the treatment of a proliferative disease or disorder in a subject and/or for use in improving the response of a subject to anticancer immunotherapy. The application further discloses pharmaceutical compositions comprising such a specific ACKR2 modulator and one or more immune checkpoint inhibitors
Original languageEnglish
Patent numberWO 2021/009251
IPC A61K39/395; A61K48/00; A61P35/00; C07K16/28; C12N15/113
Priority date15/07/19
Filing date15/07/20
Publication statusPublished - 21 Jan 2021


Dive into the research topics of 'Specific ACKR2 modulators for use in therapy'. Together they form a unique fingerprint.

Cite this